Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 5-year average of 21.69%, near the low end of its 5-year range (0.00%–154.15%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
0.00%
DEBT TO ASSETS RATIO AVG 3Y
4.46%
DEBT TO ASSETS RATIO AVG 5Y
21.69%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 836 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Aclarion, Inc.
Market Cap
$6.66M
Debt to Assets Ratio
0.00%
TTM Avg
0.00%
3Y Avg
4.46%
5Y Avg
21.69%
Market Cap
$6.62M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.74M
Debt to Assets Ratio
0.54%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.51M
Debt to Assets Ratio
0.07%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.98M
Debt to Assets Ratio
0.17%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.00M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.00M
Debt to Assets Ratio
0.11%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aclarion, Inc. (ACON) | $6.66M | 0.00% | 0.00% | 4.46% | 21.69% |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.62M | 0.00% | N/A | N/A | N/A |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.74M | 0.54% | N/A | N/A | N/A |
| Biomerica, Inc. (BMRA)vs › | $6.54M | 0.28% | N/A | N/A | N/A |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.51M | 0.07% | N/A | N/A | N/A |
| Exicure, Inc. (XCUR)vs › | $6.82M | 0.00% | N/A | N/A | N/A |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $6.98M | 0.17% | N/A | N/A | N/A |
| Mangoceuticals, Inc. (MGRX)vs › | $7.00M | 0.02% | N/A | N/A | N/A |
| Co-Diagnostics, Inc. (CODX)vs › | $7.00M | 0.11% | N/A | N/A | N/A |
| Femasys Inc. (FEMY)vs › | $6.30M | 0.39% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
16.20
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 25.16% |
| 2024-03-31 | 17.98% |
| 2023-12-31 | 45.77% |
| 2023-09-30 | 47.14% |
| 2023-06-30 | 5.93% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 110.62% |
| 2021-12-31 | 105.85% |
| 2021-09-30 | 75.34% |
| 2021-06-30 | 154.15% |
| 2020-12-31 | 184.00% |
